טוען...
MPLA and AddaVax(®) Adjuvants Fail to Promote Intramuscular LaAg Vaccine Protectiveness against Experimental Cutaneous Leishmaniasis
There is so far no vaccine approved for human leishmaniasis, mainly because of the lack of appropriate adjuvants. This study aimed to evaluate in mice the capacity of a mixture of monophosphoryl lipid A (MPLA) and AddaVax(®) adjuvants in enhancing the efficacy of a Leishvacin(®)-like vaccine compris...
שמור ב:
| הוצא לאור ב: | Microorganisms |
|---|---|
| Main Authors: | , , , , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
MDPI
2021
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8230739/ https://ncbi.nlm.nih.gov/pubmed/34207948 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/microorganisms9061272 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|